14-16 November 2018

Boston

Join the Exploding Neoantigen-Based Therapeutics Community

The NeoAg Summit is the leading industry-focused meeting dedicated to ensuring improved identification, utilization and immune monitoring, to ensure the successful clinical development of truly individualized neoantigen-based vaccines and immunotherapies.

The NeoAg Summit US is the leading end-to-end summit dedicated to supercharging the targeting of cell and vaccine immunotherapies to accelerate to clinic safe, effective and scalable individualized neoantigen-based therapies.

In a rapidly evolving field, the NeoAg Summit is the key platform to benchmark your therapy, exclusively network with the key thought leaders and overcome major challenges from prediction and discovery of neoantigens to clinical development and manufacturing.

Previously we focused extensively on the technologies for identifying neoantigens and the bioinformatics approaches that have been developed to enhance epitope prediction, however as we look to move the field forward the 3rd Annual NeoAg Summit Boston will take a deep dive into ensuring the neoantigens selected are immunogenic and manufacturing processes are cost-effective.

Hear maturing clinical updates on current programs, regulations for products and how to manufacture for individualized therapeutics. Gathering the pioneers as we continue on the journey to clinical development of neoantigen-based immunotherapies the NeoAg Summit will share key insights to guide your commercial roadmap to success.